English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1516519      線上人數 : 192
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/22880


    題名: Lithium Imidazole for the Synthesis of Potential Biological Active Compound
    作者: 黃建智(Jiann-Jyh Huang);翁豐富(Wong, Fung Fuh)
    貢獻者: 藥學院藥物化學研究所
    日期: 2006-08-23?
    上傳時間: 2009-09-07 12:26:19 (UTC+8)
    摘要: A convenient method for the synthesis 1-substituted imidazoles was developed by the reaction of α-bromoketone with lithium imidazole. The reaction gave the desired products in improved yields without the formation of 1,3-disubstituted imidazolium salts. A mechanistic study on the newly developed nucleophilic substitution was elucidated by use of a strictly geometric 21-bromo-3α-hydroxyl-3β-methoxymethyl-5α-pregnan-20-one. Data from HPLC and proton NMR suggested an epoxide as the intermediate. Lithium imidazole was thus applied for the synthesis of biologically active 3α-hydroxyl-21-(1’-imidazolyl)-3β-methoxymethyl-5α-pregnan-20-one. The key steps were the improvement of stereoselectivity for acetyl isomers in C-17 and the introduction of imidazole into the core structure by use of lithium imidazole. This latter key step provided the desired product in 82% yield without the formation of 1,3-disubstituted imidazolium salt as impurity, which is generally observed in traditional method.
    關聯: 2006 藥物化學研討會
    顯示於類別:[藥物化學研究所] 會議論文

    文件中的檔案:

    沒有與此文件相關的檔案.



    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋